BioCentury | Feb 27, 2021
Product Development

The growing pool of gene editing delivery companies

...around that opportunity.On Tuesday, base editing company Beam Therapeutics Inc. (NASDAQ:BEAM) announced the acquisition of Guide Therapeutics Inc....
BioCentury | Feb 23, 2021
Deals

Beam adds ex-hepatic delivery tech to base editing toolkit with Guide buyout

...with what we’ve built.”Julie Sunderland, a managing director at Biomatics Capital and the chair of Guide Therapeutics Inc....
...company raised $260 million last month in a private placement with crossover investors. Paul Bonanos Beam Therapeutics Inc.Guide Therapeutics Inc....
BioCentury | Jul 11, 2016
Financial News

Guided Therapeutics proposes private placement of convertible preferred stock and warrants

Guided Therapeutics Inc. (OTCBB:GTHP), Norcross, Ga. Business: Diagnostic Date announced: 2016-07-01 Type: Private placement of convertible preferred stock and warrants To be raised: Up to $5 million Shares: 5,000 Price: $1,000 Shares outstanding prior: 29.9...
BioCentury | Jun 13, 2016
Company News

Guided Therapeutics, Shenguo Medical deal

Guided Therapeutics granted Shenghuo exclusive rights to manufacture and commercialize LuViva Advanced Cervical Scan and associated disposable products in China, Taiwan, Brunei, Cambodia, Laos, Myanmar, Philippines, Thailand, Vietnam and Singapore. Guided Therapeutics will issue a...
BioCentury | Sep 28, 2015
Financial News

Guided Therapeutics completes private placement of convertible preferred stock and warrants

Guided Therapeutics Inc. (OTCBB:GTHP), Norcross, Ga. Business: Diagnostic Date completed: 2015-09-03 Type: Private placement of convertible preferred stock and warrants Raised: $1.3 million Shares: 1,734 Price: $750 Shares outstanding prior: 113.5 million Placement agent: Ladenburg...
BioCentury | Jul 20, 2015
Financial News

Guided Therapeutics completes

Guided Therapeutics Inc. (OTCBB:GTHP), Norcross, Ga. Business: Diagnostic Date completed: 2015-06-30 Raised: $2.5 million Shares: 3,334 Price: $750 Shares outstanding prior: 113.7 million Placement agent: Ladenburg Thalmann Investor: Accredited investors Note: Guided Therapeutics raised $2.5...
BioCentury | Jun 1, 2015
Clinical News

LuViva Advanced Cervical Scan regulatory update

FDA said Guided Therapeutics’ PMA amendment for LuViva Advanced Cervical Scan non-invasive cervical cancer test was not approvable and said more patient data would be necessary. According to the company, FDA said it was willing...
BioCentury | Apr 20, 2015
Financial News

Guided Therapeutics completes private placement of common stock and warrants

Guided Therapeutics Inc. (OTCBB:GTHP), Norcross, Ga. Business: Diagnostic Date completed: 2015-04-15 Type: Private placement of common stock and warrants Raised: $720,000 Shares: 4 million Price: $0.18 Shares after offering: 101.2 million Investor: Accredited investors Note:...
BioCentury | Sep 22, 2014
Financial News

Guided Therapeutics proposes private placement of common stock and warrants

Guided Therapeutics Inc. (OTCBB:GTHP), Norcross, Ga. Business: Diagnostic Date announced: 2014-09-08 Type: Private placement of common stock and warrants To be raised: $200,000 Shares: 651,042 Price: $0.31 Shares outstanding prior: 78.2 million Investor: Item Medical...
BioCentury | Sep 8, 2014
Clinical News

LuViva Advanced Cervical Scan: Postmarketing study started

Guided Therapeutics began a blinded, U.S. and Peruvian postmarketing trial to compare LuViva Advanced Cervical Scan vs. visual examination with acetic acid, cytology, HPV, colposcopy and biopsy in 600-800 women. LuViva is approved in the...
Items per page:
1 - 10 of 55
BioCentury | Feb 27, 2021
Product Development

The growing pool of gene editing delivery companies

...around that opportunity.On Tuesday, base editing company Beam Therapeutics Inc. (NASDAQ:BEAM) announced the acquisition of Guide Therapeutics Inc....
BioCentury | Feb 23, 2021
Deals

Beam adds ex-hepatic delivery tech to base editing toolkit with Guide buyout

...with what we’ve built.”Julie Sunderland, a managing director at Biomatics Capital and the chair of Guide Therapeutics Inc....
...company raised $260 million last month in a private placement with crossover investors. Paul Bonanos Beam Therapeutics Inc.Guide Therapeutics Inc....
BioCentury | Jul 11, 2016
Financial News

Guided Therapeutics proposes private placement of convertible preferred stock and warrants

Guided Therapeutics Inc. (OTCBB:GTHP), Norcross, Ga. Business: Diagnostic Date announced: 2016-07-01 Type: Private placement of convertible preferred stock and warrants To be raised: Up to $5 million Shares: 5,000 Price: $1,000 Shares outstanding prior: 29.9...
BioCentury | Jun 13, 2016
Company News

Guided Therapeutics, Shenguo Medical deal

Guided Therapeutics granted Shenghuo exclusive rights to manufacture and commercialize LuViva Advanced Cervical Scan and associated disposable products in China, Taiwan, Brunei, Cambodia, Laos, Myanmar, Philippines, Thailand, Vietnam and Singapore. Guided Therapeutics will issue a...
BioCentury | Sep 28, 2015
Financial News

Guided Therapeutics completes private placement of convertible preferred stock and warrants

Guided Therapeutics Inc. (OTCBB:GTHP), Norcross, Ga. Business: Diagnostic Date completed: 2015-09-03 Type: Private placement of convertible preferred stock and warrants Raised: $1.3 million Shares: 1,734 Price: $750 Shares outstanding prior: 113.5 million Placement agent: Ladenburg...
BioCentury | Jul 20, 2015
Financial News

Guided Therapeutics completes

Guided Therapeutics Inc. (OTCBB:GTHP), Norcross, Ga. Business: Diagnostic Date completed: 2015-06-30 Raised: $2.5 million Shares: 3,334 Price: $750 Shares outstanding prior: 113.7 million Placement agent: Ladenburg Thalmann Investor: Accredited investors Note: Guided Therapeutics raised $2.5...
BioCentury | Jun 1, 2015
Clinical News

LuViva Advanced Cervical Scan regulatory update

FDA said Guided Therapeutics’ PMA amendment for LuViva Advanced Cervical Scan non-invasive cervical cancer test was not approvable and said more patient data would be necessary. According to the company, FDA said it was willing...
BioCentury | Apr 20, 2015
Financial News

Guided Therapeutics completes private placement of common stock and warrants

Guided Therapeutics Inc. (OTCBB:GTHP), Norcross, Ga. Business: Diagnostic Date completed: 2015-04-15 Type: Private placement of common stock and warrants Raised: $720,000 Shares: 4 million Price: $0.18 Shares after offering: 101.2 million Investor: Accredited investors Note:...
BioCentury | Sep 22, 2014
Financial News

Guided Therapeutics proposes private placement of common stock and warrants

Guided Therapeutics Inc. (OTCBB:GTHP), Norcross, Ga. Business: Diagnostic Date announced: 2014-09-08 Type: Private placement of common stock and warrants To be raised: $200,000 Shares: 651,042 Price: $0.31 Shares outstanding prior: 78.2 million Investor: Item Medical...
BioCentury | Sep 8, 2014
Clinical News

LuViva Advanced Cervical Scan: Postmarketing study started

Guided Therapeutics began a blinded, U.S. and Peruvian postmarketing trial to compare LuViva Advanced Cervical Scan vs. visual examination with acetic acid, cytology, HPV, colposcopy and biopsy in 600-800 women. LuViva is approved in the...
Items per page:
1 - 10 of 55